Review



raji b cell lines  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC raji b cell lines
    ( A ) Analysis of ChIP-seq data of p300 (black), histone (blue), NFATc1 (green), and in situ Hi-C data at the IL10 locus using public datasets ( GSE32465 , GSE29611 , and GSE63525 ) of GM12878 human immortalized B cells. ( B to E <t>)</t> <t>Raji</t> <t>B</t> cells were electroporated with vectors expressing Cas9 and sgRNAs targeting NFAT-binding motifs in IL10 CNS-12 or mock vectors. (B) Schematic diagram of the NFAT-binding motifs in IL10 CNS-12, identified with rVISTA (Transfac matrices, similarity score of 0.85). Red arrows indicate sgRNA targeting sites. (C) qRT-PCR analysis of IL10 mRNA in electroporated human Raji B cells, expressed as fold change relative to unstimulated cells. [(D) and (E)] Representative flow cytometry plots (D) and frequency (E) of IL-10 + cells in Raji B cells ( n = 3 for mock, sgRNA 1, and sgRNA 2). A FMO control for IL-10 is shown in (D). ( F ) IL-10 concentrations in culture supernatants of Raji B cells measured at 4 and 24 hours ( n = 3 for mock, sgRNA 1, and sgRNA 2). Data are pooled from three independent experiments [(C), (E), and (F)]. Data are presented as means ± SEM. Statistical analysis was performed using a two-tailed unpaired Student’s t test [(C), (E), and (F)]: * P < 0.05, ** P < 0.01, and **** P < 0.0001.
    Raji B Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 3500 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/raji b cell lines/product/ATCC
    Average 99 stars, based on 3500 article reviews
    raji b cell lines - by Bioz Stars, 2026-06
    99/100 stars

    Images

    1) Product Images from "Conserved noncoding sequence-9 regulates NFATc1-mediated IL-10 expression in B cells to control inflammatory responses"

    Article Title: Conserved noncoding sequence-9 regulates NFATc1-mediated IL-10 expression in B cells to control inflammatory responses

    Journal: Science Advances

    doi: 10.1126/sciadv.aec7779

    ( A ) Analysis of ChIP-seq data of p300 (black), histone (blue), NFATc1 (green), and in situ Hi-C data at the IL10 locus using public datasets ( GSE32465 , GSE29611 , and GSE63525 ) of GM12878 human immortalized B cells. ( B to E ) Raji B cells were electroporated with vectors expressing Cas9 and sgRNAs targeting NFAT-binding motifs in IL10 CNS-12 or mock vectors. (B) Schematic diagram of the NFAT-binding motifs in IL10 CNS-12, identified with rVISTA (Transfac matrices, similarity score of 0.85). Red arrows indicate sgRNA targeting sites. (C) qRT-PCR analysis of IL10 mRNA in electroporated human Raji B cells, expressed as fold change relative to unstimulated cells. [(D) and (E)] Representative flow cytometry plots (D) and frequency (E) of IL-10 + cells in Raji B cells ( n = 3 for mock, sgRNA 1, and sgRNA 2). A FMO control for IL-10 is shown in (D). ( F ) IL-10 concentrations in culture supernatants of Raji B cells measured at 4 and 24 hours ( n = 3 for mock, sgRNA 1, and sgRNA 2). Data are pooled from three independent experiments [(C), (E), and (F)]. Data are presented as means ± SEM. Statistical analysis was performed using a two-tailed unpaired Student’s t test [(C), (E), and (F)]: * P < 0.05, ** P < 0.01, and **** P < 0.0001.
    Figure Legend Snippet: ( A ) Analysis of ChIP-seq data of p300 (black), histone (blue), NFATc1 (green), and in situ Hi-C data at the IL10 locus using public datasets ( GSE32465 , GSE29611 , and GSE63525 ) of GM12878 human immortalized B cells. ( B to E ) Raji B cells were electroporated with vectors expressing Cas9 and sgRNAs targeting NFAT-binding motifs in IL10 CNS-12 or mock vectors. (B) Schematic diagram of the NFAT-binding motifs in IL10 CNS-12, identified with rVISTA (Transfac matrices, similarity score of 0.85). Red arrows indicate sgRNA targeting sites. (C) qRT-PCR analysis of IL10 mRNA in electroporated human Raji B cells, expressed as fold change relative to unstimulated cells. [(D) and (E)] Representative flow cytometry plots (D) and frequency (E) of IL-10 + cells in Raji B cells ( n = 3 for mock, sgRNA 1, and sgRNA 2). A FMO control for IL-10 is shown in (D). ( F ) IL-10 concentrations in culture supernatants of Raji B cells measured at 4 and 24 hours ( n = 3 for mock, sgRNA 1, and sgRNA 2). Data are pooled from three independent experiments [(C), (E), and (F)]. Data are presented as means ± SEM. Statistical analysis was performed using a two-tailed unpaired Student’s t test [(C), (E), and (F)]: * P < 0.05, ** P < 0.01, and **** P < 0.0001.

    Techniques Used: ChIP-sequencing, In Situ, Hi-C, Expressing, Binding Assay, Quantitative RT-PCR, Flow Cytometry, Control, Two Tailed Test



    Similar Products

    99
    ATCC raji b cell lines
    ( A ) Analysis of ChIP-seq data of p300 (black), histone (blue), NFATc1 (green), and in situ Hi-C data at the IL10 locus using public datasets ( GSE32465 , GSE29611 , and GSE63525 ) of GM12878 human immortalized B cells. ( B to E <t>)</t> <t>Raji</t> <t>B</t> cells were electroporated with vectors expressing Cas9 and sgRNAs targeting NFAT-binding motifs in IL10 CNS-12 or mock vectors. (B) Schematic diagram of the NFAT-binding motifs in IL10 CNS-12, identified with rVISTA (Transfac matrices, similarity score of 0.85). Red arrows indicate sgRNA targeting sites. (C) qRT-PCR analysis of IL10 mRNA in electroporated human Raji B cells, expressed as fold change relative to unstimulated cells. [(D) and (E)] Representative flow cytometry plots (D) and frequency (E) of IL-10 + cells in Raji B cells ( n = 3 for mock, sgRNA 1, and sgRNA 2). A FMO control for IL-10 is shown in (D). ( F ) IL-10 concentrations in culture supernatants of Raji B cells measured at 4 and 24 hours ( n = 3 for mock, sgRNA 1, and sgRNA 2). Data are pooled from three independent experiments [(C), (E), and (F)]. Data are presented as means ± SEM. Statistical analysis was performed using a two-tailed unpaired Student’s t test [(C), (E), and (F)]: * P < 0.05, ** P < 0.01, and **** P < 0.0001.
    Raji B Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/raji b cell lines/product/ATCC
    Average 99 stars, based on 1 article reviews
    raji b cell lines - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    96
    ATCC human burkitt s lymphoma cell line
    ( A ) Analysis of ChIP-seq data of p300 (black), histone (blue), NFATc1 (green), and in situ Hi-C data at the IL10 locus using public datasets ( GSE32465 , GSE29611 , and GSE63525 ) of GM12878 human immortalized B cells. ( B to E <t>)</t> <t>Raji</t> <t>B</t> cells were electroporated with vectors expressing Cas9 and sgRNAs targeting NFAT-binding motifs in IL10 CNS-12 or mock vectors. (B) Schematic diagram of the NFAT-binding motifs in IL10 CNS-12, identified with rVISTA (Transfac matrices, similarity score of 0.85). Red arrows indicate sgRNA targeting sites. (C) qRT-PCR analysis of IL10 mRNA in electroporated human Raji B cells, expressed as fold change relative to unstimulated cells. [(D) and (E)] Representative flow cytometry plots (D) and frequency (E) of IL-10 + cells in Raji B cells ( n = 3 for mock, sgRNA 1, and sgRNA 2). A FMO control for IL-10 is shown in (D). ( F ) IL-10 concentrations in culture supernatants of Raji B cells measured at 4 and 24 hours ( n = 3 for mock, sgRNA 1, and sgRNA 2). Data are pooled from three independent experiments [(C), (E), and (F)]. Data are presented as means ± SEM. Statistical analysis was performed using a two-tailed unpaired Student’s t test [(C), (E), and (F)]: * P < 0.05, ** P < 0.01, and **** P < 0.0001.
    Human Burkitt S Lymphoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human burkitt s lymphoma cell line/product/ATCC
    Average 96 stars, based on 1 article reviews
    human burkitt s lymphoma cell line - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    86
    Jackson Laboratory raji cell lines
    ( A ) Analysis of ChIP-seq data of p300 (black), histone (blue), NFATc1 (green), and in situ Hi-C data at the IL10 locus using public datasets ( GSE32465 , GSE29611 , and GSE63525 ) of GM12878 human immortalized B cells. ( B to E <t>)</t> <t>Raji</t> <t>B</t> cells were electroporated with vectors expressing Cas9 and sgRNAs targeting NFAT-binding motifs in IL10 CNS-12 or mock vectors. (B) Schematic diagram of the NFAT-binding motifs in IL10 CNS-12, identified with rVISTA (Transfac matrices, similarity score of 0.85). Red arrows indicate sgRNA targeting sites. (C) qRT-PCR analysis of IL10 mRNA in electroporated human Raji B cells, expressed as fold change relative to unstimulated cells. [(D) and (E)] Representative flow cytometry plots (D) and frequency (E) of IL-10 + cells in Raji B cells ( n = 3 for mock, sgRNA 1, and sgRNA 2). A FMO control for IL-10 is shown in (D). ( F ) IL-10 concentrations in culture supernatants of Raji B cells measured at 4 and 24 hours ( n = 3 for mock, sgRNA 1, and sgRNA 2). Data are pooled from three independent experiments [(C), (E), and (F)]. Data are presented as means ± SEM. Statistical analysis was performed using a two-tailed unpaired Student’s t test [(C), (E), and (F)]: * P < 0.05, ** P < 0.01, and **** P < 0.0001.
    Raji Cell Lines, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/raji cell lines/product/Jackson Laboratory
    Average 86 stars, based on 1 article reviews
    raji cell lines - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    99
    ATCC cell lines raji
    ( A ) Analysis of ChIP-seq data of p300 (black), histone (blue), NFATc1 (green), and in situ Hi-C data at the IL10 locus using public datasets ( GSE32465 , GSE29611 , and GSE63525 ) of GM12878 human immortalized B cells. ( B to E <t>)</t> <t>Raji</t> <t>B</t> cells were electroporated with vectors expressing Cas9 and sgRNAs targeting NFAT-binding motifs in IL10 CNS-12 or mock vectors. (B) Schematic diagram of the NFAT-binding motifs in IL10 CNS-12, identified with rVISTA (Transfac matrices, similarity score of 0.85). Red arrows indicate sgRNA targeting sites. (C) qRT-PCR analysis of IL10 mRNA in electroporated human Raji B cells, expressed as fold change relative to unstimulated cells. [(D) and (E)] Representative flow cytometry plots (D) and frequency (E) of IL-10 + cells in Raji B cells ( n = 3 for mock, sgRNA 1, and sgRNA 2). A FMO control for IL-10 is shown in (D). ( F ) IL-10 concentrations in culture supernatants of Raji B cells measured at 4 and 24 hours ( n = 3 for mock, sgRNA 1, and sgRNA 2). Data are pooled from three independent experiments [(C), (E), and (F)]. Data are presented as means ± SEM. Statistical analysis was performed using a two-tailed unpaired Student’s t test [(C), (E), and (F)]: * P < 0.05, ** P < 0.01, and **** P < 0.0001.
    Cell Lines Raji, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell lines raji/product/ATCC
    Average 99 stars, based on 1 article reviews
    cell lines raji - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    97
    ATCC b cell lymphoma cell line raji
    Impact of Rlip modification on CD19 CAR-T cell binding efficiency, CAR expression, and functional phenotype. (A) . Schematic of the anti-CD19 CAR construct. (B) . Flow-cytometry histograms showing CD19 CAR expression in untransduced human T cells versus anti-CD19 CAR-T cells. (C). Flowcytometry histograms of RhB positivity in CAR-T and Rlip-CAR-T cells (reflecting Rlip binding efficiency). (D) . Flow-cytometry dot plots showing CD19 CAR expression levels in CAR-T and Rlip-CAR-T cells. (E) . Quantitative analysis of CD19 CAR expression ratios between CAR-T and Rlip-CART cells. (F) . Cytotoxic activity of CAR-T and Rlip-CAR-T cells against Nalm-6 and <t>Raji</t> cells at the indicated E:T ratios. (G) . Flow-cytometry dot plots showing memory-phenotype distribution of CAR-T and Rlip-CAR-T cells stained for CD62L and CD45RA. (H) . Quantitative analysis of T-cell memory subsets (TSCM, TCM, TEM, TTE) in CAR-T and Rlip-CAR-T cells. (I) . Quantitative analysis of activation-marker (CD69, CD25) expression in CAR-T and Rlip-CAR-T cells. (J) . Quantitative analysis of exhaustion-marker (PD-1, LAG-3) expression in CAR-T and Rlip-CAR-T cells. All data are obtained from at least three donors and presented as mean ± SD; ns, not significant. Cytotoxic activity (F) was analyzed by two-way ANOVA; all other quantitative comparisons (E, H–J) used two-tailed unpaired t-tests.
    B Cell Lymphoma Cell Line Raji, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/b cell lymphoma cell line raji/product/ATCC
    Average 97 stars, based on 1 article reviews
    b cell lymphoma cell line raji - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    99
    ATCC cd20 positive cell lines
    Impact of Rlip modification on CD19 CAR-T cell binding efficiency, CAR expression, and functional phenotype. (A) . Schematic of the anti-CD19 CAR construct. (B) . Flow-cytometry histograms showing CD19 CAR expression in untransduced human T cells versus anti-CD19 CAR-T cells. (C). Flowcytometry histograms of RhB positivity in CAR-T and Rlip-CAR-T cells (reflecting Rlip binding efficiency). (D) . Flow-cytometry dot plots showing CD19 CAR expression levels in CAR-T and Rlip-CAR-T cells. (E) . Quantitative analysis of CD19 CAR expression ratios between CAR-T and Rlip-CART cells. (F) . Cytotoxic activity of CAR-T and Rlip-CAR-T cells against Nalm-6 and <t>Raji</t> cells at the indicated E:T ratios. (G) . Flow-cytometry dot plots showing memory-phenotype distribution of CAR-T and Rlip-CAR-T cells stained for CD62L and CD45RA. (H) . Quantitative analysis of T-cell memory subsets (TSCM, TCM, TEM, TTE) in CAR-T and Rlip-CAR-T cells. (I) . Quantitative analysis of activation-marker (CD69, CD25) expression in CAR-T and Rlip-CAR-T cells. (J) . Quantitative analysis of exhaustion-marker (PD-1, LAG-3) expression in CAR-T and Rlip-CAR-T cells. All data are obtained from at least three donors and presented as mean ± SD; ns, not significant. Cytotoxic activity (F) was analyzed by two-way ANOVA; all other quantitative comparisons (E, H–J) used two-tailed unpaired t-tests.
    Cd20 Positive Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd20 positive cell lines/product/ATCC
    Average 99 stars, based on 1 article reviews
    cd20 positive cell lines - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    ATCC raji cell lines
    Impact of Rlip modification on CD19 CAR-T cell binding efficiency, CAR expression, and functional phenotype. (A) . Schematic of the anti-CD19 CAR construct. (B) . Flow-cytometry histograms showing CD19 CAR expression in untransduced human T cells versus anti-CD19 CAR-T cells. (C). Flowcytometry histograms of RhB positivity in CAR-T and Rlip-CAR-T cells (reflecting Rlip binding efficiency). (D) . Flow-cytometry dot plots showing CD19 CAR expression levels in CAR-T and Rlip-CAR-T cells. (E) . Quantitative analysis of CD19 CAR expression ratios between CAR-T and Rlip-CART cells. (F) . Cytotoxic activity of CAR-T and Rlip-CAR-T cells against Nalm-6 and <t>Raji</t> cells at the indicated E:T ratios. (G) . Flow-cytometry dot plots showing memory-phenotype distribution of CAR-T and Rlip-CAR-T cells stained for CD62L and CD45RA. (H) . Quantitative analysis of T-cell memory subsets (TSCM, TCM, TEM, TTE) in CAR-T and Rlip-CAR-T cells. (I) . Quantitative analysis of activation-marker (CD69, CD25) expression in CAR-T and Rlip-CAR-T cells. (J) . Quantitative analysis of exhaustion-marker (PD-1, LAG-3) expression in CAR-T and Rlip-CAR-T cells. All data are obtained from at least three donors and presented as mean ± SD; ns, not significant. Cytotoxic activity (F) was analyzed by two-way ANOVA; all other quantitative comparisons (E, H–J) used two-tailed unpaired t-tests.
    Raji Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/raji cell lines/product/ATCC
    Average 99 stars, based on 1 article reviews
    raji cell lines - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    ATCC burkitt lymphoma cell line raji
    Impact of Rlip modification on CD19 CAR-T cell binding efficiency, CAR expression, and functional phenotype. (A) . Schematic of the anti-CD19 CAR construct. (B) . Flow-cytometry histograms showing CD19 CAR expression in untransduced human T cells versus anti-CD19 CAR-T cells. (C). Flowcytometry histograms of RhB positivity in CAR-T and Rlip-CAR-T cells (reflecting Rlip binding efficiency). (D) . Flow-cytometry dot plots showing CD19 CAR expression levels in CAR-T and Rlip-CAR-T cells. (E) . Quantitative analysis of CD19 CAR expression ratios between CAR-T and Rlip-CART cells. (F) . Cytotoxic activity of CAR-T and Rlip-CAR-T cells against Nalm-6 and <t>Raji</t> cells at the indicated E:T ratios. (G) . Flow-cytometry dot plots showing memory-phenotype distribution of CAR-T and Rlip-CAR-T cells stained for CD62L and CD45RA. (H) . Quantitative analysis of T-cell memory subsets (TSCM, TCM, TEM, TTE) in CAR-T and Rlip-CAR-T cells. (I) . Quantitative analysis of activation-marker (CD69, CD25) expression in CAR-T and Rlip-CAR-T cells. (J) . Quantitative analysis of exhaustion-marker (PD-1, LAG-3) expression in CAR-T and Rlip-CAR-T cells. All data are obtained from at least three donors and presented as mean ± SD; ns, not significant. Cytotoxic activity (F) was analyzed by two-way ANOVA; all other quantitative comparisons (E, H–J) used two-tailed unpaired t-tests.
    Burkitt Lymphoma Cell Line Raji, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/burkitt lymphoma cell line raji/product/ATCC
    Average 99 stars, based on 1 article reviews
    burkitt lymphoma cell line raji - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    ATCC htb 20 raji cell line atcc cat
    Impact of Rlip modification on CD19 CAR-T cell binding efficiency, CAR expression, and functional phenotype. (A) . Schematic of the anti-CD19 CAR construct. (B) . Flow-cytometry histograms showing CD19 CAR expression in untransduced human T cells versus anti-CD19 CAR-T cells. (C). Flowcytometry histograms of RhB positivity in CAR-T and Rlip-CAR-T cells (reflecting Rlip binding efficiency). (D) . Flow-cytometry dot plots showing CD19 CAR expression levels in CAR-T and Rlip-CAR-T cells. (E) . Quantitative analysis of CD19 CAR expression ratios between CAR-T and Rlip-CART cells. (F) . Cytotoxic activity of CAR-T and Rlip-CAR-T cells against Nalm-6 and <t>Raji</t> cells at the indicated E:T ratios. (G) . Flow-cytometry dot plots showing memory-phenotype distribution of CAR-T and Rlip-CAR-T cells stained for CD62L and CD45RA. (H) . Quantitative analysis of T-cell memory subsets (TSCM, TCM, TEM, TTE) in CAR-T and Rlip-CAR-T cells. (I) . Quantitative analysis of activation-marker (CD69, CD25) expression in CAR-T and Rlip-CAR-T cells. (J) . Quantitative analysis of exhaustion-marker (PD-1, LAG-3) expression in CAR-T and Rlip-CAR-T cells. All data are obtained from at least three donors and presented as mean ± SD; ns, not significant. Cytotoxic activity (F) was analyzed by two-way ANOVA; all other quantitative comparisons (E, H–J) used two-tailed unpaired t-tests.
    Htb 20 Raji Cell Line Atcc Cat, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/htb 20 raji cell line atcc cat/product/ATCC
    Average 99 stars, based on 1 article reviews
    htb 20 raji cell line atcc cat - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Analysis of ChIP-seq data of p300 (black), histone (blue), NFATc1 (green), and in situ Hi-C data at the IL10 locus using public datasets ( GSE32465 , GSE29611 , and GSE63525 ) of GM12878 human immortalized B cells. ( B to E ) Raji B cells were electroporated with vectors expressing Cas9 and sgRNAs targeting NFAT-binding motifs in IL10 CNS-12 or mock vectors. (B) Schematic diagram of the NFAT-binding motifs in IL10 CNS-12, identified with rVISTA (Transfac matrices, similarity score of 0.85). Red arrows indicate sgRNA targeting sites. (C) qRT-PCR analysis of IL10 mRNA in electroporated human Raji B cells, expressed as fold change relative to unstimulated cells. [(D) and (E)] Representative flow cytometry plots (D) and frequency (E) of IL-10 + cells in Raji B cells ( n = 3 for mock, sgRNA 1, and sgRNA 2). A FMO control for IL-10 is shown in (D). ( F ) IL-10 concentrations in culture supernatants of Raji B cells measured at 4 and 24 hours ( n = 3 for mock, sgRNA 1, and sgRNA 2). Data are pooled from three independent experiments [(C), (E), and (F)]. Data are presented as means ± SEM. Statistical analysis was performed using a two-tailed unpaired Student’s t test [(C), (E), and (F)]: * P < 0.05, ** P < 0.01, and **** P < 0.0001.

    Journal: Science Advances

    Article Title: Conserved noncoding sequence-9 regulates NFATc1-mediated IL-10 expression in B cells to control inflammatory responses

    doi: 10.1126/sciadv.aec7779

    Figure Lengend Snippet: ( A ) Analysis of ChIP-seq data of p300 (black), histone (blue), NFATc1 (green), and in situ Hi-C data at the IL10 locus using public datasets ( GSE32465 , GSE29611 , and GSE63525 ) of GM12878 human immortalized B cells. ( B to E ) Raji B cells were electroporated with vectors expressing Cas9 and sgRNAs targeting NFAT-binding motifs in IL10 CNS-12 or mock vectors. (B) Schematic diagram of the NFAT-binding motifs in IL10 CNS-12, identified with rVISTA (Transfac matrices, similarity score of 0.85). Red arrows indicate sgRNA targeting sites. (C) qRT-PCR analysis of IL10 mRNA in electroporated human Raji B cells, expressed as fold change relative to unstimulated cells. [(D) and (E)] Representative flow cytometry plots (D) and frequency (E) of IL-10 + cells in Raji B cells ( n = 3 for mock, sgRNA 1, and sgRNA 2). A FMO control for IL-10 is shown in (D). ( F ) IL-10 concentrations in culture supernatants of Raji B cells measured at 4 and 24 hours ( n = 3 for mock, sgRNA 1, and sgRNA 2). Data are pooled from three independent experiments [(C), (E), and (F)]. Data are presented as means ± SEM. Statistical analysis was performed using a two-tailed unpaired Student’s t test [(C), (E), and (F)]: * P < 0.05, ** P < 0.01, and **** P < 0.0001.

    Article Snippet: A20 and Raji B cell lines were obtained from the American Type Culture Collection (MD, USA).

    Techniques: ChIP-sequencing, In Situ, Hi-C, Expressing, Binding Assay, Quantitative RT-PCR, Flow Cytometry, Control, Two Tailed Test

    Impact of Rlip modification on CD19 CAR-T cell binding efficiency, CAR expression, and functional phenotype. (A) . Schematic of the anti-CD19 CAR construct. (B) . Flow-cytometry histograms showing CD19 CAR expression in untransduced human T cells versus anti-CD19 CAR-T cells. (C). Flowcytometry histograms of RhB positivity in CAR-T and Rlip-CAR-T cells (reflecting Rlip binding efficiency). (D) . Flow-cytometry dot plots showing CD19 CAR expression levels in CAR-T and Rlip-CAR-T cells. (E) . Quantitative analysis of CD19 CAR expression ratios between CAR-T and Rlip-CART cells. (F) . Cytotoxic activity of CAR-T and Rlip-CAR-T cells against Nalm-6 and Raji cells at the indicated E:T ratios. (G) . Flow-cytometry dot plots showing memory-phenotype distribution of CAR-T and Rlip-CAR-T cells stained for CD62L and CD45RA. (H) . Quantitative analysis of T-cell memory subsets (TSCM, TCM, TEM, TTE) in CAR-T and Rlip-CAR-T cells. (I) . Quantitative analysis of activation-marker (CD69, CD25) expression in CAR-T and Rlip-CAR-T cells. (J) . Quantitative analysis of exhaustion-marker (PD-1, LAG-3) expression in CAR-T and Rlip-CAR-T cells. All data are obtained from at least three donors and presented as mean ± SD; ns, not significant. Cytotoxic activity (F) was analyzed by two-way ANOVA; all other quantitative comparisons (E, H–J) used two-tailed unpaired t-tests.

    Journal: Frontiers in Immunology

    Article Title: Erythrocyte membrane–liposome coating sustains circulation stability and targeted tumor therapy of CAR-T cells

    doi: 10.3389/fimmu.2026.1799107

    Figure Lengend Snippet: Impact of Rlip modification on CD19 CAR-T cell binding efficiency, CAR expression, and functional phenotype. (A) . Schematic of the anti-CD19 CAR construct. (B) . Flow-cytometry histograms showing CD19 CAR expression in untransduced human T cells versus anti-CD19 CAR-T cells. (C). Flowcytometry histograms of RhB positivity in CAR-T and Rlip-CAR-T cells (reflecting Rlip binding efficiency). (D) . Flow-cytometry dot plots showing CD19 CAR expression levels in CAR-T and Rlip-CAR-T cells. (E) . Quantitative analysis of CD19 CAR expression ratios between CAR-T and Rlip-CART cells. (F) . Cytotoxic activity of CAR-T and Rlip-CAR-T cells against Nalm-6 and Raji cells at the indicated E:T ratios. (G) . Flow-cytometry dot plots showing memory-phenotype distribution of CAR-T and Rlip-CAR-T cells stained for CD62L and CD45RA. (H) . Quantitative analysis of T-cell memory subsets (TSCM, TCM, TEM, TTE) in CAR-T and Rlip-CAR-T cells. (I) . Quantitative analysis of activation-marker (CD69, CD25) expression in CAR-T and Rlip-CAR-T cells. (J) . Quantitative analysis of exhaustion-marker (PD-1, LAG-3) expression in CAR-T and Rlip-CAR-T cells. All data are obtained from at least three donors and presented as mean ± SD; ns, not significant. Cytotoxic activity (F) was analyzed by two-way ANOVA; all other quantitative comparisons (E, H–J) used two-tailed unpaired t-tests.

    Article Snippet: Human breast cancer cell line HCC1806, ovarian cancer cell line OVCAR3, B-cell lymphoma cell line Raji, human monocytic leukemia cell line THP-1, and B-cell precursor leukemia cell line NALM-6 were purchased from the American Type Culture Collection (ATCC).

    Techniques: Modification, Binding Assay, Expressing, Functional Assay, Construct, Flow Cytometry, Activity Assay, Staining, Activation Assay, Marker, Two Tailed Test